Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 71

1.

Structure of the complement C5a receptor bound to the extra-helical antagonist NDT9513727.

Robertson N, Rappas M, Doré AS, Brown J, Bottegoni G, Koglin M, Cansfield J, Jazayeri A, Cooke RM, Marshall FH.

Nature. 2018 Jan 3;553(7686):111-114. doi: 10.1038/nature25025.

PMID:
29300009
2.

Validation of Farsi Translation of the Ocular Surface Disease Index.

Pakdel F, Gohari MR, Jazayeri AS, Amani A, Pirmarzdashti N, Aghaee H.

J Ophthalmic Vis Res. 2017 Jul-Sep;12(3):301-304. doi: 10.4103/jovr.jovr_92_16.

3.

Corrigendum: Crystal structure of the GLP-1 receptor bound to a peptide agonist.

Jazayeri A, Rappas M, Brown AJH, Kean J, Errey JC, Robertson NJ, Fiez-Vandal C, Andrews SP, Congreve M, Bortolato A, Mason JS, Baig AH, Teobald I, Doré AS, Weir M, Cooke RM, Marshall FH.

Nature. 2017 Aug 3;548(7665):122. doi: 10.1038/nature23311. Epub 2017 Jul 12.

PMID:
28700581
4.

Crystal structure of the GLP-1 receptor bound to a peptide agonist.

Jazayeri A, Rappas M, Brown AJH, Kean J, Errey JC, Robertson NJ, Fiez-Vandal C, Andrews SP, Congreve M, Bortolato A, Mason JS, Baig AH, Teobald I, Doré AS, Weir M, Cooke RM, Marshall FH.

Nature. 2017 Jun 8;546(7657):254-258. doi: 10.1038/nature22800. Epub 2017 May 31. Erratum in: Nature. 2017 Aug 3;548(7665):122.

PMID:
28562585
5.

Structural insight into allosteric modulation of protease-activated receptor 2.

Cheng RKY, Fiez-Vandal C, Schlenker O, Edman K, Aggeler B, Brown DG, Brown GA, Cooke RM, Dumelin CE, Doré AS, Geschwindner S, Grebner C, Hermansson NO, Jazayeri A, Johansson P, Leong L, Prihandoko R, Rappas M, Soutter H, Snijder A, Sundström L, Tehan B, Thornton P, Troast D, Wiggin G, Zhukov A, Marshall FH, Dekker N.

Nature. 2017 May 4;545(7652):112-115. doi: 10.1038/nature22309. Epub 2017 Apr 26.

PMID:
28445455
6.

Asymptomatic Epstein-Barr Virus Shedding in the Urine of Kidney Transplant Recipients: Case Reports and Review of the Literature.

Rahbar M, Poormand G, Mahmoodi MK, Jazayeri A, Jazayeri SM.

Infect Dis Rep. 2016 Dec 31;8(4):6817. doi: 10.4081/idr.2016.6817. eCollection 2016 Dec 31.

7.
8.

Intracellular allosteric antagonism of the CCR9 receptor.

Oswald C, Rappas M, Kean J, Doré AS, Errey JC, Bennett K, Deflorian F, Christopher JA, Jazayeri A, Mason JS, Congreve M, Cooke RM, Marshall FH.

Nature. 2016 Dec 15;540(7633):462-465. doi: 10.1038/nature20606. Epub 2016 Dec 7.

PMID:
27926729
9.

Real time monitoring of membrane GPCR reconstitution by plasmon waveguide resonance: on the role of lipids.

Calmet P, De Maria M, Harté E, Lamb D, Serrano-Vega M, Jazayeri A, Tschammer N, Alves ID.

Sci Rep. 2016 Nov 8;6:36181. doi: 10.1038/srep36181.

10.

Structurally Enabled Discovery of Adenosine A2A Receptor Antagonists.

Jazayeri A, Andrews SP, Marshall FH.

Chem Rev. 2017 Jan 11;117(1):21-37. doi: 10.1021/acs.chemrev.6b00119. Epub 2016 Jun 22. Review.

PMID:
27333206
11.

Evaluation of success after second Ahmed glaucoma valve implantation.

Nilforushan N, Yadgari M, Jazayeri AA, Karimi N.

Indian J Ophthalmol. 2016 Mar;64(3):206-10. doi: 10.4103/0301-4738.181740.

12.

Extra-helical binding site of a glucagon receptor antagonist.

Jazayeri A, Doré AS, Lamb D, Krishnamurthy H, Southall SM, Baig AH, Bortolato A, Koglin M, Robertson NJ, Errey JC, Andrews SP, Teobald I, Brown AJ, Cooke RM, Weir M, Marshall FH.

Nature. 2016 May 12;533(7602):274-7. doi: 10.1038/nature17414. Epub 2016 Apr 25.

PMID:
27111510
13.

Comparison between visual field defect in pigmentary glaucoma and primary open-angle glaucoma.

Nilforushan N, Yadgari M, Jazayeri A.

Int Ophthalmol. 2016 Oct;36(5):637-42. doi: 10.1007/s10792-016-0173-z. Epub 2016 Jan 13.

PMID:
26758071
14.

Allele-Specific Inhibition of Rhodopsin With an Antisense Oligonucleotide Slows Photoreceptor Cell Degeneration.

Murray SF, Jazayeri A, Matthes MT, Yasumura D, Yang H, Peralta R, Watt A, Freier S, Hung G, Adamson PS, Guo S, Monia BP, LaVail MM, McCaleb ML.

Invest Ophthalmol Vis Sci. 2015 Oct;56(11):6362-75. doi: 10.1167/iovs.15-16400.

15.

Fragment and Structure-Based Drug Discovery for a Class C GPCR: Discovery of the mGlu5 Negative Allosteric Modulator HTL14242 (3-Chloro-5-[6-(5-fluoropyridin-2-yl)pyrimidin-4-yl]benzonitrile).

Christopher JA, Aves SJ, Bennett KA, Doré AS, Errey JC, Jazayeri A, Marshall FH, Okrasa K, Serrano-Vega MJ, Tehan BG, Wiggin GR, Congreve M.

J Med Chem. 2015 Aug 27;58(16):6653-64. doi: 10.1021/acs.jmedchem.5b00892. Epub 2015 Aug 12.

PMID:
26225459
16.

Conformational thermostabilisation of corticotropin releasing factor receptor 1.

Kean J, Bortolato A, Hollenstein K, Marshall FH, Jazayeri A.

Sci Rep. 2015 Jul 10;5:11954. doi: 10.1038/srep11954.

17.

From G Protein-coupled Receptor Structure Resolution to Rational Drug Design.

Jazayeri A, Dias JM, Marshall FH.

J Biol Chem. 2015 Aug 7;290(32):19489-95. doi: 10.1074/jbc.R115.668251. Epub 2015 Jun 22. Review.

18.

Treatment of Blepharospasm in Schwartz-Jampel Syndrome: Botulinum Toxin A Injection or Surgery.

Kashkouli MB, Shahrzad S, Jazayeri AA, Abtahi MB.

Ophthal Plast Reconstr Surg. 2017 May/Jun;33(3S Suppl 1):S47-S49. doi: 10.1097/IOP.0000000000000503.

PMID:
26020714
19.

Implications of metabotropic glutamate receptor structures for drug discovery in neurotherapeutics.

Jazayeri A, Marshall F.

Expert Rev Neurother. 2015 Feb;15(2):123-5. doi: 10.1586/14737175.2015.1001369. Epub 2015 Jan 12.

PMID:
25578566
20.

Large scale expression and purification of the rat 5-HT2c receptor.

He X, Robertson N, Jazayeri A, Gasperina AG, Schertler G, Li X.

Protein Expr Purif. 2015 Feb;106:1-9. doi: 10.1016/j.pep.2014.10.010. Epub 2014 Oct 28.

PMID:
25448824
21.

Structure of class C GPCR metabotropic glutamate receptor 5 transmembrane domain.

Doré AS, Okrasa K, Patel JC, Serrano-Vega M, Bennett K, Cooke RM, Errey JC, Jazayeri A, Khan S, Tehan B, Weir M, Wiggin GR, Marshall FH.

Nature. 2014 Jul 31;511(7511):557-62. doi: 10.1038/nature13396. Epub 2014 Jul 6.

PMID:
25042998
22.

A passivity criterion for sampled-data bilateral teleoperation systems.

Jazayeri A, Tavakoli M.

IEEE Trans Haptics. 2013 Jul-Sep;6(3):363-9. doi: 10.1109/TOH.2012.73.

PMID:
24808332
23.

Eighteen-point abobotulinum toxin a upper face rejuvenation: an eye plastic perspective on 845 subjects.

Kashkouli MB, Amani A, Jamshidian-Tehrani M, Yousefi S, Jazayeri AA.

Ophthal Plast Reconstr Surg. 2014 May-Jun;30(3):219-24. doi: 10.1097/IOP.0000000000000053.

PMID:
24481513
24.

Anticonvulsant effect of Diazoxide against Dichlorvos-induced seizures in mice.

Jazayeri A, Zolfaghari S, Ostadhadi S.

ScientificWorldJournal. 2013 Dec 17;2013:697305. doi: 10.1155/2013/697305. eCollection 2013.

25.

Monoclonal anti-β1-adrenergic receptor antibodies activate G protein signaling in the absence of β-arrestin recruitment.

Hutchings CJ, Cseke G, Osborne G, Woolard J, Zhukov A, Koglin M, Jazayeri A, Pandya-Pathak J, Langmead CJ, Hill SJ, Weir M, Marshall FH.

MAbs. 2014 Jan-Feb;6(1):246-61.

26.

Breastfeeding and pain relief in full-term neonates during immunization injections: a clinical randomized trial.

Modarres M, Jazayeri A, Rahnama P, Montazeri A.

BMC Anesthesiol. 2013 Sep 13;13(1):22. doi: 10.1186/1471-2253-13-22.

27.

Structure of class B GPCR corticotropin-releasing factor receptor 1.

Hollenstein K, Kean J, Bortolato A, Cheng RK, Doré AS, Jazayeri A, Cooke RM, Weir M, Marshall FH.

Nature. 2013 Jul 25;499(7459):438-43. doi: 10.1038/nature12357. Epub 2013 Jul 17.

PMID:
23863939
28.

Structure Activity Relationships of α-L-LNA Modified Phosphorothioate Gapmer Antisense Oligonucleotides in Animals.

Seth PP, Jazayeri A, Yu J, Allerson CR, Bhat B, Swayze EE.

Mol Ther Nucleic Acids. 2012 Sep 18;1:e47. doi: 10.1038/mtna.2012.34.

29.

Synthesis and antisense properties of fluoro cyclohexenyl nucleic acid (F-CeNA), a nuclease stable mimic of 2'-fluoro RNA.

Seth PP, Yu J, Jazayeri A, Pallan PS, Allerson CR, Østergaard ME, Liu F, Herdewijn P, Egli M, Swayze EE.

J Org Chem. 2012 Jun 1;77(11):5074-85. doi: 10.1021/jo300594b. Epub 2012 May 18.

30.

Antisense oligonucleotide therapy for TTR amyloidosis.

Benson MD, Pandey S, Witchell D, Jazayeri A, Siwkowski A, Monia B, Kluve-Beckerman B.

Amyloid. 2011 Jun;18 Suppl 1:60. doi: 10.3109/13506129.2011.574354021. No abstract available. Erratum in: Amyloid. 2011 Jun;18 Suppl 1:60.

PMID:
21838433
31.

Thermostabilisation of an agonist-bound conformation of the human adenosine A(2A) receptor.

Lebon G, Bennett K, Jazayeri A, Tate CG.

J Mol Biol. 2011 Jun 10;409(3):298-310. doi: 10.1016/j.jmb.2011.03.075. Epub 2011 Apr 9.

32.

The properties of thermostabilised G protein-coupled receptors (StaRs) and their use in drug discovery.

Robertson N, Jazayeri A, Errey J, Baig A, Hurrell E, Zhukov A, Langmead CJ, Weir M, Marshall FH.

Neuropharmacology. 2011 Jan;60(1):36-44. doi: 10.1016/j.neuropharm.2010.07.001. Epub 2010 Jul 17.

PMID:
20624408
33.

Mre11-Rad50-Nbs1-dependent processing of DNA breaks generates oligonucleotides that stimulate ATM activity.

Jazayeri A, Balestrini A, Garner E, Haber JE, Costanzo V.

EMBO J. 2008 Jul 23;27(14):1953-62. doi: 10.1038/emboj.2008.128. Epub 2008 Jul 3.

34.

Study of the numerical artifacts in differential analysis of highly conducting gratings.

Khavasi A, Mehrany K, Jazayeri AH.

Opt Lett. 2008 Jan 15;33(2):159-61.

PMID:
18197225
35.

Multidisciplinary intervention for reducing malnutrition among children in the Islamic Republic of Iran.

Sheikholeslam R, Kimiagar M, Siasi F, Abdollahi Z, Jazayeri A, Keyghobadi K, Ghaffarpoor M, Noroozi F, Kalantari M, Minaei N, Eslami F, Hormozdyari H.

East Mediterr Health J. 2004 Nov;10(6):844-52.

PMID:
16335772
36.

ATM- and cell cycle-dependent regulation of ATR in response to DNA double-strand breaks.

Jazayeri A, Falck J, Lukas C, Bartek J, Smith GC, Lukas J, Jackson SP.

Nat Cell Biol. 2006 Jan;8(1):37-45. Epub 2005 Dec 4.

PMID:
16327781
37.

Saccharomyces cerevisiae Sin3p facilitates DNA double-strand break repair.

Jazayeri A, McAinsh AD, Jackson SP.

Proc Natl Acad Sci U S A. 2004 Feb 10;101(6):1644-9. Epub 2004 Jan 7.

38.

Diagnosis of a rudimentary uterine horn in pregnancy.

Sutkin G, Jazayeri A.

J Ultrasound Med. 2003 Sep;22(9):985-8. No abstract available.

PMID:
14510273
39.

Tocolysis does not improve neonatal outcome in patients with preterm rupture of membranes.

Jazayeri A, Jazayeri MK, Sutkin G.

Am J Perinatol. 2003 May;20(4):189-93.

PMID:
12874729
40.

Statistical tests of demographic heterogeneity theories.

Mueller LD, Drapeau MD, Adams CS, Hammerle CW, Doyal KM, Jazayeri AJ, Ly T, Beguwala SA, Mamidi AR, Rose MR.

Exp Gerontol. 2003 Apr;38(4):373-86.

PMID:
12670624
41.

Diagnosis and management of abdominal pregnancy. A case report.

Jazayeri A, Davis TA, Contreras DN.

J Reprod Med. 2002 Dec;47(12):1047-9.

PMID:
12516328
42.

Randomized trial of lidocaine ointment versus placebo for the treatment of postpartum perineal pain.

Minassian VA, Jazayeri A, Prien SD, Timmons RL, Stumbo K.

Obstet Gynecol. 2002 Dec;100(6):1239-43.

PMID:
12468168
43.

Favorable outcome in a pregnancy with complete fetal heart block and severe bradycardia.

Minassian VA, Jazayeri A.

Obstet Gynecol. 2002 Nov;100(5 Pt 2):1087-9.

PMID:
12423815
44.

Enhanced calcium signaling and acid secretion in parietal cells isolated from gastrin-deficient mice.

Hinkle KL, Bane GC, Jazayeri A, Samuelson LC.

Am J Physiol Gastrointest Liver Physiol. 2003 Jan;284(1):G145-53. Epub 2002 Sep 11.

45.

A prospective study of vaginal pH as a predictor of preterm delivery.

Jazayeri A, Arnold H, Jazayeri MK, Spellacy WN.

J Matern Fetal Neonatal Med. 2002 Jan;11(1):30-3.

PMID:
12380605
46.

Is meconium passage a risk factor for maternal infection in term pregnancies?

Jazayeri A, Jazayeri MK, Sahinler M, Sincich T.

Obstet Gynecol. 2002 Apr;99(4):548-52.

PMID:
12039108
47.

Screening the yeast genome for new DNA-repair genes.

Jazayeri A, Jackson SP.

Genome Biol. 2002;3(4):REVIEWS1009. Epub 2002 Mar 13. Review.

48.

Prolonged-interval delivery between the first and second twin. A case report.

Jazayeri A, Mamlok V, Dorsett MM, Porter KB.

J Reprod Med. 2002 Feb;47(2):167-9.

PMID:
11883357
49.

Repeated antenatal corticosteroid treatments. Do they reduce neonatal morbidity?

Jazayeri A, Gavrila D, Sincich T.

J Reprod Med. 2001 Sep;46(9):788-90.

PMID:
11584477
50.

Fetal erythropoietin levels in pregnancies complicated by meconium passage: does meconium suggest fetal hypoxia?

Jazayeri A, Politz L, Tsibris JC, Queen T, Spellacy WN.

Am J Obstet Gynecol. 2000 Jul;183(1):188-90.

PMID:
10920329

Supplemental Content

Loading ...
Support Center